Moussy Y, Moussy F
Johns Hopkins University, Department of Mechanical Engineering, Baltimore, MD 21218-2686, USA.
Artif Cells Blood Substit Immobil Biotechnol. 1995;23(2):163-73. doi: 10.3109/10731199509117936.
This paper introduces a newly developed 2-channel bioartificial pancreas for the treatment of type I diabetes. In this device, insulin secreting cells (islets of Langerhans) are placed between 2 semi-permeable membranes that form a flat rectangular chamber. One side of the chamber is in contact with blood from an artery and the other side with blood from a vein. In addition to the diffusive transfer of glucose and insulin, the pressure difference between the artery and the vein creates an ultrafiltration flux through the islet chamber. This diffusion and ultrafiltration flux carries glucose from the artery to the islets, and insulin from the islets to the vein. The bioartificial pancreas has a compact geometry and the blood channels were designed to prevent blood clotting. The predicted insulin release in response to a square-wave and a triangular-wave glucose stimulation is given for the bioartificial pancreas of dimensions necessary for implantation in diabetic patients.
本文介绍了一种新开发的用于治疗I型糖尿病的双通道生物人工胰腺。在该装置中,胰岛素分泌细胞(胰岛)置于形成扁平矩形腔室的两个半透膜之间。腔室的一侧与动脉血接触,另一侧与静脉血接触。除了葡萄糖和胰岛素的扩散传递外,动脉和静脉之间的压力差产生了通过胰岛腔室的超滤通量。这种扩散和超滤通量将葡萄糖从动脉输送到胰岛,将胰岛素从胰岛输送到静脉。该生物人工胰腺具有紧凑的几何形状,并且血液通道设计用于防止血液凝固。给出了针对植入糖尿病患者所需尺寸的生物人工胰腺,在方波和三角波葡萄糖刺激下预测的胰岛素释放情况。